ENZC got enough money to manufacture and distribute their immune boosting product from somewhere. They didn’t dilute the stock. Then Regeneron comes up with ENZC’s patented technology. We are hoping that they licensed the technology. But there are other possibilities. Could be ENZC sold the rights to the technology or since they were partners in the lab, Regeneron already had rights to it. But the question remains, where did ENZC get the money for their product? Maybe we’ll see it in the coming filings? Correct me with proof if I am wrong. I just want answers. What are your thoughts?
News 
Market Data 
Discover 
